Prof Durgesh Dwivedi, department of radiodiagnosis, who led the study, said, “We have developed a non-invasive method using Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI). Our initial study on a small sample size has found the method to be effective. Now an advanced study is being done on a larger sample to establish its efficacy.”
“It is a first-of-its-kind method in the world for detecting kidney cancer. It will also suggest which medicines can be given to patients with least side effects. The findings of our pioneering research study have recently been published in the high-impact and peer reviewed International Journal of Cancer and Clinical Research,” he informed.
According to Prof Dwivedi, traditionally, biopsy is done to confirm cancer in kidney cells. In this procedure, tissues of the tumour on the kidney are taken out by inserting a needle. However, since cancer patients are immune-compromised, there are chances of infection in inserting a needle in the organ as it cuts into the tissues.
On the other hand, DCE-MRI — an advanced version of MRI — is a combination of non-invasive imaging, genomics and radiomix.
“Simultaneously, these patients also underwent biopsy tests, the results of which confirmed cancer. This proved that the diagnosis done through DCE-MRI is as effective as biopsy.
The study is now being conducted on a larger sample of patients to further consolidate our findings.
As part of the study, experts also conducted DCE-MRI of 19 other patients who had already been diagnosed with cancer through biopsy and were under medication for some time.
The objective of this research was to examine how effective drugs and therapies (anti-angiogenic and immune) are in preventing growth of cancer cells in these patients.
“The DCE-MRI results were analysed along with genetics and observable physical properties of the patients. The minute observations not only facilitated identification of biomarkers required to diagnose cancer but also helped in examining whether a drug/therapy is reducing or increasing inflammation in a patient or causing any side effects,” said Prof Dwivedi.
Source: IANS
Stay connected with us on social media platform for instant update click here to join our Twitter, & Facebook
We are now on Telegram. Click here to join our channel (@TechiUpdate) and stay updated with the latest Technology headlines.
For all the latest Health News Click Here
For the latest news and updates, follow us on Google News.
Denial of responsibility! NewsAzi is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected]. The content will be deleted within 24 hours.
